NFE2L2 and cervical carcinoma: Our understanding of PGRN-stimulated NFE2L2/ARE signaling not only characterizes the antioxidant role of PGRN under oxidative stress conditions but also provides new therapeutic interventions for PGRN in cervical cancer.